HLA-DRB1 allele frequencies and C4 copy number variation in Finnish sarcoidosis patients and associations with disease prognosis

Human Immunology

Volumn 73, Issue 1, 2012, Pages 93-100

  Wennerström, Annika ^a   Pietinalho, Anne ^b   Vauhkonen, Hanna ^a   Lahtela, Laura ^a   Palikhe, Anil ^a   Hedman, Jouni ^c   Purokivi, Minna ^d   Varkki, Essi ^e   Seppänen, Mikko ^b   Lokki, Marja Liisa ^a   Selroos, Olof ^f  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c SOUTH KARELIA CENTRAL HOSPITAL   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF OULU   (Finland)

^f Semeco AB   (Sweden)

Author keywords

Complement C4; DRB1; Human leukocyte antigen (HLA); Prognosis; Sarcoidosis

Indexed keywords

COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C4B; HLA DR ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; FEMALE; FINLAND; FOLLOW UP; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; SARCOIDOSIS;

ADULT; ALLELES; COMPLEMENT C4A; COMPLEMENT C4B; DNA COPY NUMBER VARIATIONS; FEMALE; FINLAND; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HLA-DRB1 CHAINS; HUMANS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; SARCOIDOSIS; YOUNG ADULT;

EID: 84355162800     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.10.016     Document Type: Article

References (46)

1. Iannuzzi M.C., Rybicki B.A., Teirstein A.S. Sarcoidosis. N Engl J Med 2007, 357:2153-2165.
2. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999, 160:736-755.
3. Milman N., Selroos O. Pulmonary sarcoidosis in the Nordic countries 1950-1982. II. Course and prognosis. Sarcoidosis 1990, 7:113-118.
4. Pietinalho A., Ohmichi M., Löfroos A.B., Hiraga Y., Selroos O. The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy-proven cases. Sarcoidosis Vasc Diffuse Lung Dis 2000, 17:158-166.
5. Pietinalho A., Ohmichi M., Hirasawa M., Hiraga Y., Löfroos A.B., Selroos O. Familial sarcoidosis in Finland and Hokkaido, Japan-a comparative study. Respir Med 1999, 93:408-412.
6. Rybicki B.A., Iannuzzi M.C., Frederick M.M., Thompson B.W., Rossman M.D., Bresnitz E.A., et al. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001, 164:2085-2091.
7. Pietinalho A., Ohmichi M., Hiraga Y., Löfroos A.B., Selroos O. The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan. A comparative analysis of 571 Finnish and 686 Japanese patients. Sarcoidosis Vasc Diffuse Lung Dis 1996, 13:159-166.
8. Pietinalho A., Hiraga Y., Hosoda Y., Löfroos A.B., Yamaguchi M., Selroos O. The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study. Sarcoidosis 1995, 12:61-67.
9. Hillerdal G., Nöu E., Osterman K., Schmekel B. Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis 1984, 130:29-32.
10. Smith G., Brownell I., Sanchez M., Prystowsky S. Advances in the genetics of sarcoidosis. Clin Genet 2008, 73:401-412.
11. Grunewald J. Genetics of sarcoidosis. Curr Opin Pulm Med 2008, 14:434-439.
12. Schürmann M., Reichel P., Müller-Myhsok B., Schlaak M., Müller-Quernheim J., Schwinger E. Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 2001, 164:840-846.
13. Iannuzzi M.C., Iyengar S.K., Gray-McGuire C., Elston R.C., Baughman R.P., Donohue J.F., et al. Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun 2005, 6:509-518.
14. Hofmann S., Franke A., Fischer A., Jacobs G., Nothnagel M., Gaede K.I., et al. Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis. Nat Genet 2008, 40:1103-1106.
15. Berlin M., Fogdell-Hahn A., Olerup O., Eklund A., Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997, 156:1601-1605.
16. Foley P.J., McGrath D.S., Puscinska E., Petrek M., Kolek V., Drabek J., et al. Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis. Am J Respir Cell Mol Biol 2001, 25:272-277.
17. Voorter C.E., Drent M., van den Berg-Loonen E.M. Severe pulmonary sarcoidosis is strongly associated with the haplotype HLA-DQB1*0602-DRB1*150101. Hum Immunol 2005, 66:826-835.
18. Mrazek F., Holla L.I., Hutyrova B., Znojil V., Vasku A., Kolek V., et al. Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Lofgren's syndrome in Czech patients with sarcoidosis. Tissue Antigens 2005, 65:163-171.
19. Grunewald J., Brynedal B., Darlington P., Nisell M., Cederlund K., Hillert J., et al. Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients. Respir Res 2010, 11:25.
20. Sato H., Woodhead F.A., Ahmad T., Grutters J.C., Spagnolo P., van den Bosch J.M., et al. Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. Hum Mol Genet 2010, 19:4100-4111.
21. Karp D.R., Marthandan N., Marsh S.G., Ahn C., Arnett F.C., Deluca D.S., et al. Novel sequence feature variant type analysis of the HLA genetic association in systemic sclerosis. Hum Mol Genet 2010, 19:707-719.
22. Voorter C.E., Amicosante M., Berretta F., Groeneveld L., Drent M., van den Berg-Loonen E.M. HLA class II amino acid epitopes as susceptibility markers of sarcoidosis. Tissue Antigens 2007, 70:18-27.
23. Germain R.N. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994, 76:287-299.
24. Stern L.J., Brown J.H., Jardetzky T.S., Gorga J.C., Urban R.G., Strominger J.L., et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994, 368:215-221.
25. Blanchong C.A., Chung E.K., Rupert K.L., Yang Y., Yang Z., Zhou B., et al. Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4. Int Immunopharmacol 2001, 1:365-392.
26. Samano E.S., Ribeiro Lde M., Gorescu R.G., Rocha K.C., Grumach A.S. Involvement of C4 allotypes in the pathogenesis of human diseases. Rev Hosp Clin Fac Med Sao Paulo 2004, 59:138-144.
27. Pietinalho A., Tukiainen P., Haahtela T., Persson T., Selroos O. Early treatment of stage II sarcoidosis improves 5-year pulmonary function. Chest 2002, 121:24-31. Finnish Pulmonary Sarcoidosis Study Group.
28. Viljanen A.A., Halttunen P.K., Kreus K.E., Viljanen B.C. Spirometric studies in non-smoking, healthy adults. Scand J Clin Lab Invest Suppl 1982, 159:5-20.
29. Seppänen M., Suvilehto J., Lokki M.L., Notkola I.L., Järvinen A., Jarva H., et al. Immunoglobulins and complement factor C4 in adult rhinosinusitis. Clin Exp Immunol 2006, 145:219-227.
30. Palikhe A., Sinisalo J., Seppänen M., Valtonen V., Nieminen M.S., Lokki M.L. Human MHC region harbors both susceptibility and protective haplotypes for coronary artery disease. Tissue Antigens 2007, 69:47-55.
31. Seppanen M., Lokki M.L., Notkola I.L., Mattila K., Valtonen V., Nieminen A., et al. Complement and C4 null alleles in severe chronic adult periodontitis. Scand J Immunol 2007, 65:176-181.
32. Excoffier L., Laval G., Schneider S. Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online 2005, 1:47-50.
33. Stephens M., Smith N.J., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001, 68:978-989.
34. Kanterakis S., Magira E., Rosenman K.D., Rossman M., Talsania K., Monos D.S. SKDM human leukocyte antigen (HLA) tool: a comprehensive HLA and disease associations analysis software. Hum Immunol 2008, 69:522-525.
35. Candore G., Modica M.A., Lio D., Colonna-Romano G., Listí F., Grimaldi M.P., et al. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: a genetically determined defect of C4 influences immunological parameters of healthy carriers of the haplotype. Biomed Pharmacother 2003, 57:274-277.
36. Grunewald J., Eklund A. Löfgren's syndrome: human leukocyte antigen strongly influences the disease course. Am J Respir Crit Care Med 2009, 179:307-312.
37. Grubić Z., Zunec R., Peros-Golubicić T., Tekavec-Trkanjec J., Martinez N., Alilović M., et al. HLA class I and class II frequencies in patients with sarcoidosis from Croatia: role of HLA-B8, -DRB1*0301, and -DQB1*0201 haplotype in clinical variations of the disease. Tissue Antigens 2007, 70:301-306.
38. Kallio-Laine K., Seppänen M., Aittoniemi J., Kautiainen H., Seppälä I., Valtonen V., et al. HLA-DRB1*01 allele and low plasma immunoglobulin G1 concentration may predispose to herpes-associated recurrent lymphocytic meningitis. Hum Immunol 2010, 71:179-181.
39. Palikhe A., Lokki M.L., Pussinen P.J., Paju S., Ahlberg J., Asikainen S., et al. Lymphotoxin alpha LTA+496C allele is a risk factor for periodontitis in patients with coronary artery disease. Tissue Antigens 2008, 71:530-537.
40. Pazár B., Gergely P., Nagy Z.B., Gombos T., Pozsonyi E., Rajczy K., et al. Role of HLA-DRB1 and PTPN22 genes in susceptibility to juvenile idiopathic arthritis in Hungarian patients. Clin Exp Rheumatol 2008, 26:1146-1152.
41. Rossman M.D., Thompson B., Frederick M., Maliarik M., Iannuzzi M.C., Rybicki B.A., et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 2003, 73:720-735.
42. Marotte H., Tournoud M., Cazalis M.A., Mougin B., Roy P., Miossec P. Extensive multiallelic analysis of the relationship between HLA-DRB1 and rheumatoid arthritis using a Bayesian partition model. Genes Immun 2006, 7:487-493.
43. Grunewald J., Eklund A., Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 2004, 169:696-702.
44. Yunis E.J., Larsen C.E., Fernandez-Viña M., Awdeh Z.L., Romero T., Hansen J.A., et al. Inheritable variable sizes of DNA stretches in the human MHC: conserved extended haplotypes and their fragments or blocks. Tissue Antigens 2003, 62:1-20.
45. Chen E.S., Wahlström J., Song Z., Willett M.H., Wikén M., Yung R.C., et al. T cell responses to mycobacterial catalase-peroxidase profile: a pathogenic antigen in systemic sarcoidosis. J Immunol 2008, 181:8784-8796.
46. Song Z., Marzilli L., Greenlee B.M., Chen E.S., Silver R.F., Askin F.B., et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 2005, 201:755-767.